Internal Medicine NewsSemaglutide prescribing surged in the past yearNovember 1, 2023ObesityDiabetesMixed Topics
Internal Medicine NewsBeyond semaglutide, a coming pipeline of new antiobesity medsNovember 1, 2023ObesityDiabetes
Internal Medicine NewsAnother study ties statins to T2D: Should practice change?October 31, 2023DiabetesCardiology
Internal Medicine NewsObesity boosts gestational diabetes risk in women with PCOSOctober 30, 2023ObesityDiabetesEndocrinologyWomen's Health
Internal Medicine NewsSGLT2 inhibitors in type 2 diabetes linked to lower risk of developing GI cancersOctober 30, 2023GastroenterologyDiabetes
Internal Medicine NewsHigher weight loss on tirzepatide links to seven factorsOctober 26, 2023ObesityDiabetes
Internal Medicine NewsTricyclics may raise fracture risk in type 2 diabetesOctober 25, 2023DiabetesEndocrinologyRheumatologyDepression
Internal Medicine NewsCommon meds link to sudden cardiac arrest in type 2 diabetesOctober 24, 2023DiabetesCardiology
Internal Medicine NewsAntidepressants ‘don’t blunt’ semaglutide and weight lossOctober 19, 2023ObesityDiabetesMental HealthDepressionPain
Internal Medicine NewsTaking a new obesity drug and birth control pills? Be carefulOctober 19, 2023ObesityDiabetesEndocrinologyWomen's Health
Internal Medicine NewsTestosterone replacement benefits men with type 2 diabetesOctober 18, 2023DiabetesMen's Health
Internal Medicine NewsDebate: Is lasting remission of type 2 diabetes feasible in the real-world setting?October 18, 2023Diabetes
Internal Medicine NewsMaking time to care for patients with diabetesOctober 17, 2023DiabetesBusiness of Medicine